Navigation Links
Health Technology Assessment Goes Online
Date:6/15/2011

LONDON, June 15, 2011 /PRNewswire/ --


Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course of August.

Health Technology Assessment has recently observed an unprecedented global  expansion. Clinical and cost effectiveness are assessed for pharmaceuticals in Australia, Canada and the UK, while clinical benefit is the main focus in France and Germany for new drugs. CER is rapidly gaining momentum in the US to inform federal funding decisions, while commercial US payers use clinical and economic evidence in formulary listings.

Over 12 speakers from 10 countries, including 5 HTA agencies, will deliver 13 presentations:

• National Institute for Health and Clinical Excellence  (NICE)

• Patented Medicine Prices Review Board (PMPRB)

• Spanish Agency for Health Technology  Assessment (AETS)

• Roche Products

• GlaxoSmithKline

• HIQA

• Office of Health Economics

• F. Hoffmann-La Roche

• Amgen

Key topics to discussed by expert panel include:

  • Speeding the reimbursement processes with first-hand input from prominent HTA bodies: NICE, OHE and HIQA
  • Exploring the efforts of standardisation of HTA in Europe

  • Implementing a best practice approach to value-based pricing

  • Analysing the finer points of performance-based reimbursement and its impact

  • Aligning HTA strategies with insight from leading pharma and biotech companies:  GSK, Roche and Amgen

  • Designing product development programmes to maximise reimbursement success

The online form of the event is meant to help to reach the global audience and enable experts from Europe to have a live discussion with their colleagues in US, Canada and Australia without the need to leave their desk.

' In response to the fact that we operate in a time of reduced budgets and time, this conference takes place 100% online, therefore no travelling expenses or timing conflicts would occur' says Andrea Charles, Global HTA and CER Forum Director. 'What's more, if someone misses a session, it can always be accesses online as a recorded version of live session. It also means thatnow we can easily access global audience and industry experts from United States will be able to network easily with their colleagues from Europe without the need of leaving their desk or home'.

To find out more about how Global HTA and CER Forum plans to bring together word-wide renowned experts in the field, or to join the online discussion, visit the event website: http://www.htaforumonline.com

https://www.htaforumonline.com/?utm_campaign=PressReleasesbrochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001PR2

For more information, images or press passes, contact:

PHARMA IQ
Joanna Checinska, Marketing Manager
Email: joanna.checinska@iqpc.co.uk
Phone: +44(0)2073689300



'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
3. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
4. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
5. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
6. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
7. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
10. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
11. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Global demand for enzymes is forecast to ... $7.2 billion.  This market includes enzymes used in ... production, animal feed, and other markets) and specialty ... and beverages will remain the largest market for ... products containing enzymes in developing regions.  These and ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):